Literature DB >> 11683776

Waardenburg syndrome type 3 (Klein-Waardenburg syndrome) segregating with a heterozygous deletion in the paired box domain of PAX3: a simple variant or a true syndrome?

M Tekin1, J N Bodurtha, W E Nance, A Pandya.   

Abstract

Klein-Waardenburg syndrome or Waardenburg syndrome type 3 (WS-III; MIM 148820) is characterized by the presence of musculoskeletal abnormalities in association with clinical features of Waardenburg syndrome type 1 (WS-I). Since the description of the first patient in 1947 (D. Klein, Arch Klaus Stift Vererb Forsch 1947: 22: 336-342), a few cases have been reported. Only occasional families have demonstrated autosomal-dominant inheritance of WS-III. In a previous report, a missense mutation in the paired domain of the PAX3 gene has been described in a family with dominant segregation of WS-III. In this report, we present a second family (mother and son) with typical clinical findings of WS-III segregating with a heterozygous 13-bp deletion in the paired domain of the PAX3 gene. Although homozygosity or compound heterozygosity has also been documented in patients with severe limb involvement, a consistent genotype-phenotype correlation for limb abnormalities associated with heterozygous PAX3 mutations has not previously been apparent. Heterozygous mutations could either reflect a unique dominant-negative effect or possibly the contribution of other unlinked genetic modifiers in determining the phenotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683776     DOI: 10.1034/j.1399-0004.2001.600408.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

Review 1.  Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease.

Authors:  Jennifer D Kubic; Kacey P Young; Rebecca S Plummer; Anton E Ludvik; Deborah Lang
Journal:  Pigment Cell Melanoma Res       Date:  2008-12       Impact factor: 4.693

2.  Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?

Authors:  Alona Gad; Mercy Laurino; Kenneth R Maravilla; Mark Matsushita; Wendy H Raskind
Journal:  Am J Med Genet A       Date:  2008-07-15       Impact factor: 2.802

Review 3.  Genetic insights, disease mechanisms, and biological therapeutics for Waardenburg syndrome.

Authors:  Sida Huang; Jian Song; Chufeng He; Xinzhang Cai; Kai Yuan; Lingyun Mei; Yong Feng
Journal:  Gene Ther       Date:  2021-02-25       Impact factor: 4.184

4.  Waardenburg Syndrome Expression and Penetrance.

Authors:  Myeshia V Shelby
Journal:  J Rare Dis Res Treat       Date:  2017-12-10

5.  Spectrum of novel mutations found in Waardenburg syndrome types 1 and 2: implications for molecular genetic diagnostics.

Authors:  Gabriele Wildhardt; Birgit Zirn; Luitgard M Graul-Neumann; Juliane Wechtenbruch; Markus Suckfüll; Annegret Buske; Axel Bohring; Christian Kubisch; Stefanie Vogt; Gertrud Strobl-Wildemann; Marie Greally; Oliver Bartsch; Daniela Steinberger
Journal:  BMJ Open       Date:  2013-03-18       Impact factor: 2.692

6.  Waardenburg Syndrome Type-II in Twin Siblings: An Unusual Audio-Pigmentary Disorder.

Authors:  Sadia Masood; Palwasha Jalil; Naila Ahmed Jan; Muhammad Sadique
Journal:  Cureus       Date:  2020-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.